Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework

被引:13
|
作者
Dima, Alexandra L. [1 ]
Allemann, Samuel S. [2 ]
Dunbar-Jacob, Jacqueline [3 ]
Hughes, Dyfrig A. [4 ]
Vrijens, Bernard [5 ,6 ]
Wilson, Ira B. [7 ]
机构
[1] Inst Recerca St Joan de Deu, Res & Dev Unit, Barcelona, Spain
[2] Univ Basel, Pharmaceut Care Res Grp, Basel, Switzerland
[3] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15261 USA
[4] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor, Gwynedd, Wales
[5] Univ Liege, AARDEX Grp, Liege, Belgium
[6] Univ Liege, Dept Publ Hlth, Liege, Belgium
[7] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
adherence; methodology; pharmacotherapy; RECOMMENDATIONS; VALIDATION; ROAD;
D O I
10.1111/bcp.15375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Measuring adherence to medication is complex due to the diversity of contexts in which medications are prescribed, dispensed and used. The Timelines-Events-Objectives-Sources (TEOS) framework outlined a process to operationalize adherence. We aimed to develop practical recommendations for quantification of medication adherence using self-report (SR), electronic monitoring (EM) and electronic healthcare databases (EHD) consistent with the TEOS framework for adherence operationalization. Methods An adherence methodology working group of the International Society for Medication Adherence (ESPACOMP) analysed implications of the process of medication adherence for all data sources and discussed considerations specific to SR, EM and EHD regarding the information available on the prescribing, dispensing, recommended and actual use timelines, the four events relevant for distinguishing the adherence phases, the study objectives commonly addressed with each type of data, and the potential sources of measurement error and quality criteria applicable. Results Four key implications for medication adherence measurement are common to all data sources: adherence is a comparison between two series of events (recommended and actual use); it refers to one or more specific medication(s); it applies to regular repeated events coinciding with known recommended dosing; and it requires separate measurement of the three adherence phases for a complete picture of patients' adherence. We propose recommendations deriving from these statements, and aspects to be considered in study design when measuring adherence with SR, EM and EHD using the TEOS framework. Conclusion The quality of medication adherence estimates is the result of several design choices that may optimize the data available.
引用
收藏
页码:1918 / 1927
页数:10
相关论文
共 50 条
  • [1] Measurement of adherence to inhaled corticosteroids by self-report and electronic medication monitoring
    Sun, Ye
    Jariwala, Sunit
    Reznik, Marina
    JOURNAL OF ASTHMA, 2023, 60 (07) : 1299 - 1305
  • [2] Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance
    Schroeder, Knut
    Fahey, Tom
    Hay, Alastair D.
    Montgomery, Alan
    Peters, Tim J.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2006, 59 (06) : 650 - 651
  • [3] Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries
    Wagner, GJ
    AIDS PATIENT CARE AND STDS, 2002, 16 (12) : 599 - 608
  • [4] Quantifying Glaucoma Medication Adherence: The Relationship Between Self-Report, Electronic Monitoring, and Pharmacy Refill
    Kumar, Jaya B.
    Bosworth, Hayden B.
    Sleath, Betsy
    Woolson, Sandra
    Olsen, Maren
    Danus, Susanne
    Muir, Kelly W.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (06) : 346 - 354
  • [5] Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues
    Pearson, Cynthia R.
    Simoni, Jane M.
    Hoff, Peter
    Kurth, Ann E.
    Martin, Diane P.
    AIDS AND BEHAVIOR, 2007, 11 (02) : 161 - 173
  • [6] Assessing Antiretroviral Adherence via Electronic Drug Monitoring and Self-Report: An Examination of Key Methodological Issues
    Cynthia R. Pearson
    Jane M. Simoni
    Peter Hoff
    Ann E. Kurth
    Diane P. Martin
    AIDS and Behavior, 2007, 11
  • [7] AdhereR: An Open Science Approach to Estimating Adherence to Medications Using Electronic Healthcare Databases
    Dima, Alexandra
    Allemann, Samuel
    Dediu, Dan
    MEDINFO 2019: HEALTH AND WELLBEING E-NETWORKS FOR ALL, 2019, 264 : 1451 - 1452
  • [8] Accurate Assessment of Adherence Self-Report and Clinician Report vs Electronic Monitoring of Nebulizers
    Daniels, Tracey
    Goodacre, Lynne
    Sutton, Chris
    Pollard, Kim
    Conway, Steven
    Peckham, Daniel
    CHEST, 2011, 140 (02) : 425 - 432
  • [9] Evaluation of the correlation between self-report and electronic monitoring of adherence to hypertension therapy
    Ayoade, Adedokun
    Oladipo, Idris
    BLOOD PRESSURE, 2012, 21 (03) : 161 - 166
  • [10] Adherence to Antidepressants in Underserved Communities: A Comparison of Electronic Monitoring and Self-report Measures
    McClintock, Heather F.
    BeKampis, Angela N.
    Hartmann, Erica
    Bogner, Hillary R.
    COMMUNITY MENTAL HEALTH JOURNAL, 2020, 56 (04) : 727 - 734